« Top Headlines » Open DEMAT Account in 24 hrs  ITAT Cuts ?4.85 Lakh Penalty After ?14.02 Lakh Interest Income Was Missed in ITR  ITR filed under old regime, tax calculated under new regime; Delhi ITAT gives taxpayer relief  ITAT Delhi Quashes Tax Notice on AMU PG Student’s ?18.34 Lakh Stipend, Declares It Tax-Free Under Section 10(16)  Advance tax deadline September 15: What happens if you missed the previous instalment payment?  How much gold jewellery can you keep at home? Nagpur ITAT explains rules on ownership, gifts, taxability  ?5.31 lakh TDS refund allowed by ITAT Delhi: Why absence of an original ITR did not block the taxpayer  Missed the ITR Filing Deadline? How to Claim Your Income Tax Refund and Correct Mistakes Before December 31, 2026  GST Return Preparation & ITC Analysis with TallyPrime (Hinglish Session)  GST Return Preparation & ITC Analysis with TallyPrime (Hinglish Session)  GST Return Preparation & ITC Analysis with TallyPrime (Hinglish Session)  Income-Tax Department Moves to Bring Greater Certainty to International Tax Cases «  Telecom industry for tax holiday... HC notice to finmin over non-CA tax preparers... » Cabinet to look into amendment November, 21st 2006 In a move that will boost the pharmaceutical sector, the Cabinet Committee on World Trade Organisation is expected to take up a proposal for amending the compulsory license clause in the Trade-Related Intellectual Property Rights (TRIPS) agreement.    Once this decision is taken, the Centre will propose to WTO to waive off the obligation under Article 31(f) and Article 31(h) of the TRIPS agreement, so that it can directly export pharma products to countries having insufficient or no manufacturing capacity.    Under the current circumstances, a government has an exceptional provision of allowing a pharma company to produce the patented product or process without the consent of the patent owner in case of a medical emergency.    But if the article is relaxed for India, domestic companies will be able to export the products to other countries in case of national emergencies without the authorisation of the patent holder.    Article 31(h) of TRIPS specifies that the right holder shall be paid adequate remuneration in the circumstances of each case, taking into account the economic value of the authorisation benefit.